Skip to main content

ADVERTISEMENT

skin cancer

Original Research
07/31/2024
Objective: To investigate the clinical outcomes associated with application of collagen powder in cutaneous surgery and patients’ perceptions of the procedure.
Objective: To investigate the clinical outcomes associated with application of collagen powder in cutaneous surgery and patients’ perceptions of the procedure.
Objective: To investigate the...
07/31/2024
Wounds
Case Q&A
01/15/2024
This Case Q&A discusses various types of nasolabial flaps as well as when and how they should be performed.
This Case Q&A discusses various types of nasolabial flaps as well as when and how they should be performed.
This Case Q&A discusses various...
01/15/2024
ePlasty
Addison M. Demer, MD
Q&As
05/31/2023
In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual Meeting.
In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual Meeting.
In this interview, Dr Addison...
05/31/2023
The Dermatologist
News
09/24/2021
Patients with nasal skin cancer’s quality of life (QOL) improves after surgery, according to a recent study published in JAMA Dermatology. Researchers aimed to evaluate the QOL of patients with nasal skin cancer after Mohs micrographic...
Patients with nasal skin cancer’s quality of life (QOL) improves after surgery, according to a recent study published in JAMA Dermatology. Researchers aimed to evaluate the QOL of patients with nasal skin cancer after Mohs micrographic...
Patients with nasal skin...
09/24/2021
The Dermatologist
News
09/24/2021
Fractionated laser resurfacing (FLR) shows decreased actinic keratosis (AK) and nonmelanoma skin cancer (NMSC) occurrence in patients aged 65 years and older. The results were published in The Journal of Clinical Investigation. “We tested...
Fractionated laser resurfacing (FLR) shows decreased actinic keratosis (AK) and nonmelanoma skin cancer (NMSC) occurrence in patients aged 65 years and older. The results were published in The Journal of Clinical Investigation. “We tested...
Fractionated laser resurfacing...
09/24/2021
The Dermatologist
Squamoid Eccrine Ductal Carcinoma
03/27/2021
Squamoid Eccrine Ductal Carcinoma Kelly Segars, DO,a Jared M. Gopman, MSIV,b Joshua B. Elston, MD,b William Carter, MD,c and Michael A. Harrington, MDb aNova Southeastern University College of Osteopathic Medicine, Davie, Fl;...
Squamoid Eccrine Ductal Carcinoma Kelly Segars, DO,a Jared M. Gopman, MSIV,b Joshua B. Elston, MD,b William Carter, MD,c and Michael A. Harrington, MDb aNova Southeastern University College of Osteopathic Medicine, Davie, Fl;...
Squamoid Eccrine Ductal...
03/27/2021
ePlasty
Direct Long Bone Invasion by Basal Cell Carcinoma: A Case Report and Review of the Literature
Case Report
03/27/2021
Direct Long Bone Invasion by Basal Cell Carcinoma: A Case Report and Review of the Literature Badr M. Al Majed, MD,a Stephanie L. Koonce, MD,b Dustin L. Eck, MD,b Peter Murray, MD,c and Galen Perdikis, MDa aDepartment of Plastic...
Direct Long Bone Invasion by Basal Cell Carcinoma: A Case Report and Review of the Literature Badr M. Al Majed, MD,a Stephanie L. Koonce, MD,b Dustin L. Eck, MD,b Peter Murray, MD,c and Galen Perdikis, MDa aDepartment of Plastic...
Direct Long Bone Invasion by...
03/27/2021
ePlasty
Dying for a Tan: A Survey to Assess Solarium Adherence to World Health Organization Guidelines in Australia, New Zealand, and the United Kingdom
03/27/2021
Dying for a Tan: A Survey to Assess Solarium Adherence to World Health Organization Guidelines in Australia, New Zealand, and the United Kingdom Amali Chandrasena, MBBS, BSc (Hons), Kavit Amin, MBBS, MRCS, and Barry Powell, MCh, MA,...
Dying for a Tan: A Survey to Assess Solarium Adherence to World Health Organization Guidelines in Australia, New Zealand, and the United Kingdom Amali Chandrasena, MBBS, BSc (Hons), Kavit Amin, MBBS, MRCS, and Barry Powell, MCh, MA,...
Dying for a Tan: A Survey to...
03/27/2021
ePlasty
News
08/07/2020
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
...
08/07/2020
Journal of Clinical Pathways
Case Report
10/04/2019
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular...
10/04/2019
ePlasty